Skip to main content
logo
Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
12.05
+0.25 (2.12%)
At close: Aug 7, 2026, 4:00 PM EDT
12.10
+0.05 (0.41%)
Pre-market: Aug 10, 2026, 8:08 AM EDT

Olema Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-185.15-162.45-129.47-96.66-104.79-71.1
Depreciation & Amortization
0.480.490.390.380.360.16
Stock-Based Compensation
23.3617.5922.5817.2618.8315.91
Other Adjustments
-4.27-5.12-7.02-4.120.511.5
Changes in Accounts Payable
3.234.62.512.320.35-0.68
Changes in Accrued Expenses
23.5410.9811.22.957.024.57
Changes in Other Operating Activities
-9.9-12.81-4.55-5.86-4.35-1.06
Operating Cash Flow
-148.72-146.72-104.35-83.73-82.07-50.69
Operating Cash Flow Growth
------
Capital Expenditures
---0.16--0.36-1.58
Sale of Property, Plant & Equipment
---0.01--
Purchases of Investments
-427.81-500.72-394.96-255.63-213.66-486.97
Proceeds from Sale of Investments
321.66344.96301.59250.76305.5213.1
Investing Cash Flow
-106.15-155.76-93.53-4.8591.48-275.44
Long-Term Debt Issued
-3----
Net Long-Term Debt Issued (Repaid)
-3----
Issuance of Common Stock
58.5214.81268.82133.420.481.39
Net Common Stock Issued (Repurchased)
58.5214.81268.82133.420.481.39
Other Financing Activities
-11.14-6.51----
Financing Cash Flow
256.78211.3268.82133.420.481.39
Net Cash Flow
1.91-91.1870.9444.849.89-324.74
Free Cash Flow
-148.72-146.72-104.51-83.73-82.43-52.27
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.63-1.69-1.78-1.85-2.06-1.32
Levered Free Cash Flow
-167.81-156.19-120.08-96.87-101.77-69.68
Unlevered Free Cash Flow
-184.47-175.43-132.86-105.17-103.97-70.07
SEC Filings: 10-K · 10-Q